(DKNG) DraftKings - Ratings and Ratios
Sports Betting, Fantasy Sports, iGaming, Retail Sportsbooks, NFTs
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 42.7% |
| Value at Risk 5%th | 69.6% |
| Relative Tail Risk | -0.82% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.16 |
| Alpha | -36.10 |
| CAGR/Max DD | 0.78 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.483 |
| Beta | 1.133 |
| Beta Downside | 1.489 |
| Drawdowns 3y | |
|---|---|
| Max DD | 47.80% |
| Mean DD | 16.80% |
| Median DD | 14.81% |
Description: DKNG DraftKings December 19, 2025
DraftKings Inc. (NASDAQ:DKNG) is a Boston-based digital sports entertainment platform that operates online sports betting, daily fantasy sports, iGaming (online casino games such as blackjack, roulette, baccarat, and slots), and a retail sportsbook network. The firm also licenses its betting-software to other operators and runs a digital collectibles marketplace that sells curated NFTs.
Key recent metrics (Q3 2024): revenue of $1.04 billion (+19% YoY), monthly active customers up 12% to 4.8 million, and adjusted EBITDA margin of 9.5%. Growth is driven by continued state-level legalization of sports betting in the U.S., rising discretionary spend on online gaming, and expanding partnerships with media companies that boost brand visibility. The broader Casinos & Gaming sub-industry is benefiting from a projected $10 billion increase in U.S. betting handle through 2027, according to industry analysts.
If you want a deeper quantitative dive, ValueRay’s analyst tools provide granular forecasts and scenario modeling for DKNG’s earnings trajectory.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (-267.6m TTM) > 0 and > 6% of Revenue (6% = 327.5m TTM) |
| FCFTA 0.13 (>2.0%) and ΔFCFTA 11.23pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 3.09% (prev -0.06%; Δ 3.15pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.14 (>3.0%) and CFO 667.6m > Net Income -267.6m (YES >=105%, WARN >=100%) |
| Net Debt (678.3m) to EBITDA (44.9m) ratio: 15.11 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.09 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (529.5m) change vs 12m ago 8.91% (target <= -2.0% for YES) |
| Gross Margin 47.57% (prev 38.50%; Δ 9.07pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 122.7% (prev 107.8%; Δ 14.90pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -6.01 (EBITDA TTM 44.9m / Interest Expense TTM 37.1m) >= 6 (WARN >= 3) |
Altman Z'' -6.50
| (A) 0.04 = (Total Current Assets 1.95b - Total Current Liabilities 1.78b) / Total Assets 4.62b |
| (B) -1.42 = Retained Earnings (Balance) -6.57b / Total Assets 4.62b |
| warn (B) unusual magnitude: -1.42 — check mapping/units |
| (C) -0.05 = EBIT TTM -222.7m / Avg Total Assets 4.45b |
| (D) -1.68 = Book Value of Equity -6.54b / Total Liabilities 3.89b |
| Total Rating: -6.50 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 46.59
| 1. Piotroski 4.0pt |
| 2. FCF Yield 3.40% |
| 3. FCF Margin 11.34% |
| 4. Debt/Equity 2.60 |
| 5. Debt/Ebitda 15.11 |
| 6. ROIC - WACC (= -15.95)% |
| 7. RoE -29.52% |
| 8. Rev. Trend 91.07% |
| 9. EPS Trend 77.75% |
What is the price of DKNG shares?
Over the past week, the price has changed by -1.45%, over one month by -0.37%, over three months by -0.11% and over the past year by -8.42%.
Is DKNG a buy, sell or hold?
- Strong Buy: 20
- Buy: 7
- Hold: 5
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the DKNG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 44.7 | 30.1% |
| Analysts Target Price | 44.7 | 30.1% |
| ValueRay Target Price | 34.3 | -0.1% |
DKNG Fundamental Data Overview January 12, 2026
P/S = 3.2075
P/B = 23.9069
Revenue TTM = 5.46b USD
EBIT TTM = -222.7m USD
EBITDA TTM = 44.9m USD
Long Term Debt = 1.84b USD (from longTermDebt, last quarter)
Short Term Debt = 11.5m USD (from shortTermDebt, last quarter)
Debt = 1.91b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 678.3m USD (from netDebt column, last quarter)
Enterprise Value = 18.18b USD (17.51b + Debt 1.91b - CCE 1.23b)
Interest Coverage Ratio = -6.01 (Ebit TTM -222.7m / Interest Expense TTM 37.1m)
EV/FCF = 29.38x (Enterprise Value 18.18b / FCF TTM 619.0m)
FCF Yield = 3.40% (FCF TTM 619.0m / Enterprise Value 18.18b)
FCF Margin = 11.34% (FCF TTM 619.0m / Revenue TTM 5.46b)
Net Margin = -4.90% (Net Income TTM -267.6m / Revenue TTM 5.46b)
Gross Margin = 47.57% ((Revenue TTM 5.46b - Cost of Revenue TTM 2.86b) / Revenue TTM)
Gross Margin QoQ = 71.27% (prev 43.50%)
Tobins Q-Ratio = 3.93 (Enterprise Value 18.18b / Total Assets 4.62b)
Interest Expense / Debt = 1.03% (Interest Expense 19.6m / Debt 1.91b)
Taxrate = 21.0% (US default 21%)
NOPAT = -175.9m (EBIT -222.7m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.09 (Total Current Assets 1.95b / Total Current Liabilities 1.78b)
Debt / Equity = 2.60 (Debt 1.91b / totalStockholderEquity, last quarter 732.3m)
Debt / EBITDA = 15.11 (Net Debt 678.3m / EBITDA 44.9m)
Debt / FCF = 1.10 (Net Debt 678.3m / FCF TTM 619.0m)
Total Stockholder Equity = 906.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -6.01% (Net Income -267.6m / Total Assets 4.62b)
RoE = -29.52% (Net Income TTM -267.6m / Total Stockholder Equity 906.4m)
RoCE = -8.12% (EBIT -222.7m / Capital Employed (Equity 906.4m + L.T.Debt 1.84b))
RoIC = -6.77% (negative operating profit) (NOPAT -175.9m / Invested Capital 2.60b)
WACC = 9.18% (E(17.51b)/V(19.41b) * Re(10.09%) + D(1.91b)/V(19.41b) * Rd(1.03%) * (1-Tc(0.21)))
Discount Rate = 10.09% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.36%
[DCF Debug] Terminal Value 65.07% ; FCFF base≈408.3m ; Y1≈268.0m ; Y5≈122.3m
Fair Price DCF = 2.63 (EV 1.99b - Net Debt 678.3m = Equity 1.31b / Shares 497.8m; r=9.18% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 77.75 | EPS CAGR: 40.30% | SUE: -0.78 | # QB: 0
Revenue Correlation: 91.07 | Revenue CAGR: 26.53% | SUE: -1.17 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.27 | Chg30d=+0.002 | Revisions Net=+0 | Analysts=3
EPS next Year (2026-12-31): EPS=1.63 | Chg30d=-0.014 | Revisions Net=-2 | Growth EPS=+150.8% | Growth Revenue=+22.2%
Additional Sources for DKNG Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle